Helsinki Business and Science Park (HBSP) provides a dynamic business environment with a diversified research and expert network and a Centre of Expertise within biotechnology, drug development and diagnostics, as well as food and environmental technology. Our objective is to improve the success opportunities of Finnish companies on the international market, and to improve domestic competitiveness.
Helsinki, March 15. 2013– Ductor Corp. and Hermo Pharma announced today the have been selected as a finalists for Red Herring’s Top 100 Europe award, a prestigious list honoring the year’s most promising private technology ventures from the European business region.
Plexpress announces follow-on funding of up to $2.3M to commercialise its novel TRAC (Transcript Analysis with the aid of Affinity Capture) platform for high-content gene expression analysis. The investment has been secured to commercialise the technology internationally, build up the ADMET screening service as well as to develop TRAC specifically within the oncology sector. Existing investors - Conor Technology Fund, VTT Ventures, Aloitusrahasto Vera and the Helsinki University Fund and Tekes, the Finnish Funding Agency for Technology and Innovation, have invested $1.4M initially with further milestone payments of up to $900k.
Hermo Pharma has closed its Series A round of venture funding. The series was led by Aloiturahasto Vera (Avera) Ltd. and the Helsinki University Funds.
Our politicians seem to be obsessed with the place, but what makes it so great? Equality, education – and Angry Birds